About us

The DMS Group is composed of companies with a strong innovative potential. Foremost focused on the medical imaging industry, it is aimed to extend to new horizons these last few years. By orienting its strategy toward the future and investing in R&D, the Group aims to bring out tomorrow’s solutions.

DMS Group is present on all continents through a network of more than 140 national distributors, subsidiaries, and joint ventures.

DMS Group is quoted on the Euronext Growth market in Paris (ALDMS).

Key figures

0 M
consolidated turnover 2021
0 %
of turnover generated through export

Our activities

Specialized in high technology for medical diagnosis, DMS Imaging positions itself as the French leader in the design, development, and manufacturing of medical imaging systems dedicated to radiology, bone densitometry, and posturology.

DMS Biotech supports the group’s development strategy in the field of biotechnology, particularly in technologies for the treatment of osteoarthritis and regenerative medicine based on the injection of fat stem cells. 


Last financial news:

25/10/2022 - DMS Group reveals its new ambitions and presents its strategic plan: “Imaging 2027”

Financial rendez-vous

  • April 20th 2022

    Turnover 1st trimester 2022

  • April 29th 2022

    Annual results 2021

  • July 20th 2022

    Half-year turnover 2022

  • September 30th 2022

    Half-year results 2022

  • October 20th 2022

    Turnover 3rd trimester 2022

  • January 20th 2023

    Annual turnover 2022